Literature DB >> 22793969

Case of anaphylaxis induced by rocuronium treated with sugammadex.

Fabiano Timbó Barbosa1, Rafael Martins da Cunha.   

Abstract

BACKGROUND AND OBJECTIVES: Anaphylaxis during anesthesia is a rare event that may occur in up to 1:20,000 cases and approximately 60% to 70% of these cases are secondary to the use of muscle relaxants, particularly succinylcholine and rocuronium. The aim of this report is to describe the treatment of a case of rocuronium-induced anaphylaxis with inadequate response to traditional therapy, and the case resolution after using sugammadex. CASE REPORT: A female patient, 62 years old, 72kg, was referred to the surgical center for treatment of epidural hematoma following an accident at home. She was monitored with pulse oximetry, cardioscope, and blood pressure meter for non-invasive blood pressure (BP) measurement. The baseline data were: BP 138/80 mm Hg, heart rate (HR) 80 bpm, and oxygen saturation (SaO(2)) 100% on room air. Anesthesia was induced with propofol 70 mg, fentanyl 200mg, and rocuronium 45 mg. After tracheal intubation, anaphylaxis non-responsive to conventional treatment was diagnosed. We chose the use of sugammadex 700 mg intravenously as an adjuvant agent. The patient had reversal of the anaphylactic reactions with improvement of hemodynamic profile and was operated and conducted to the intensive care unit.
CONCLUSION: In this case, sugammadex was used to reverse the hemodynamic picture caused by rocuronium-induced anaphylaxis. However, it was not possible to identify the exact mechanism for the reversal.
Copyright © 2012 Elsevier Editora Ltda. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22793969     DOI: 10.1016/S0034-7094(12)70152-6

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  2 in total

1.  Neuronal Effects of Sugammadex in combination with Rocuronium or Vecuronium.

Authors:  Martin Aldasoro; Adrian Jorda; Constanza Aldasoro; Patricia Marchio; Sol Guerra-Ojeda; Marc Gimeno-Raga; Mª Dolores Mauricio; Antonio Iradi; Elena Obrador; Jose Mª Vila; Soraya L Valles
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

2.  Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.

Authors:  Sheng-Kai Hung; Chia-Chi Yeh; Pei-Chi Ting; Cay-Huyen Chen; Ming-Chang Kao
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.